Background: Polyclonal B-cell activation induced by periodontopathic bacter
ia has been cited as being important for elevated numbers of B cells, but t
he role of bacteria in the pathogenesis of periodontal disease remains unkn
own. In this study, we used an in vitro model to investigate the activation
of immune cells by the periodontopathic bacterium Porphyromonas gingivalis
in healthy subjects.
Methods: Peripheral blood mononuclear cells (PBMC) or purified subsets of l
ymphocytes were stimulated with sonicated extracts of P. gingivalis for 24
hours. Cells were harvested and monitored for expression of CD69 by flow cy
tometry. Cytokine production (IL-10, IL-12, and IL-15) in gingivalis-stimul
ated PBMC cultures was measured by ELISA. To identify IL-10 producer cells,
a cell depletion experiment was used and confirmed by the ability of the p
urified cell population to produce IL-10. To evaluate the effect of P. ging
ivalis and IL-10, the proliferative response of purified B cells was assess
ed by [H-3] thymidine uptake.
Results: PBMC cultured with P. gingivalis led to a large number of activate
d B and natural killer (NK) cells as monitored by CD69 expression. When pos
itively sorted cells were used, the bacterium itself could directly activat
e only B cells but not NK cells, alpha beta, and gamma delta T cells. Measu
rement of B-cell regulatory cytokine production in P. gingivalis-stimulated
PBMC cultures revealed a large amount of IL-10 but no detectable IL-12 or
IL-15; the major producing cells were monocytes, not B cells or ap T cells.
When IL-10 was added to B cells in the presence of bacteria, significantly
increased B-cell proliferative responses were observed.
Conclusions: These results suggest that P. gingivalis, both directly and in
directly via macrophage IL-10, may play an important role in polyclonal B-c
ell activation associated with periodontal disease.